August 2019

In the August Editor-in-Chief's Letter, Dr. Jason Gallagher discusses how we can improve outpatient antimicrobial stewardship.

The story of penicillin and cefazolin.

Quick recognition is key to early initiation of treatment and long-term survival.

There has been increasing interest in the association between neural tube defects, dolutegravir, and integrase inhibitors as a class since 4 cases were reported in 2018.

Optimal dosing of daptomycin is unknown, but study results suggest higher doses are required for successful clinical and microbiological outcomes.

Optimizing the relationship between infection prevention and antimicrobial stewardship.

An update for clinical providers.

A novel NNRTI hits the market, but what place will it have in treatment?

Numerous studies need to be performed to ensure adequate antimicrobial dosing, partic­ularly in the setting of renal impairment and critical illness.

Fosfomycin is an attractive potential option because it does not cross-react with other antimicrobials, making it a good choice in patients with extensive drug allergies.